Increased carotid intima media thickness is associated with depletion of circulating myeloid dendritic cells in HIV-infected patients on suppressive antiretroviral treatment

Atherosclerosis

Volumn 204, Issue 2, 2009, Pages

  Lichtner, Miriam ^a   Cuomo, Maria Rosaria ^a   Rossi, Raffaella ^a   Strano, Stefano ^a   Massetti, Anna P ^a   Mastroianni, Claudio M ^a   Vullo, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atherosclerosis; Dendritic cells; HIV

Indexed keywords

C REACTIVE PROTEIN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTERIAL WALL THICKNESS; ATHEROGENESIS; ATHEROSCLEROSIS; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE DURATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; ANTI-RETROVIRAL AGENTS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CELL COUNT; DENDRITIC CELLS; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYELOID CELLS; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 67349153088     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.12.025     Document Type: Letter

References (17)

1. Hansson G.K. Inflammation atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
2. Coll B., Parra S., Villaverde C.A., et al. The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection. Stroke 38 (2007) 2477-2484
3. Yilmaz A., Lochno M., Traeg F., et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 176 (2004) 101-110
4. Bobryshev Y.V. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J 26 (2005) 1700-1704
5. Erbel C., Sato K., Meyer F.B., et al. Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol 102 (2007) 123-132
6. Weber C., Zernecke A., and Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 8 (2008) 802-815
7. Chehimi J., Campbell D.E., Azzoni L., et al. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J Immunol 168 (2002) 4796-4801
8. Killian M.S., Fujimura S.H., Hecht F.M., and Levy J.A. Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment. AIDS 20 (2006) 1247-1252
9. Schmidt B., Fujimura S.H., Martin J.N., and Levy J.A. Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy. J Clin Immunol 26 (2006) 55-64
10. Lichtner M., Rossi R., Rizza C., et al. Plasmacytoid dendritic cells count in antiretroviral-treated patients is predictive of HIV load control independent of CD4+ T-cell count. Curr HIV Res 6 (2008) 19-27
11. DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 356 (2007) 1723-1735
12. Olsen C.H., Mocroft A., O Kirk O., et al. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. HIV Med 8 (2007) 96-104
13. Hsue P.Y., Lo J.C., Franklin A., et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 109 (2004) 1603-1608
14. Currier J.S., Kendall M.A., Henry W.K., et al. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS 21 (2007) 1137-1145
15. Yilmaz A., Weber J., Cicha I., et al. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. J Am Coll Cardiol 48 (2006) 70-80
16. Dillon S.M., Robertson K.B., Pan S.C., et al. Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection. J Acquir Immune Defic Syndr 48 (2008) 1-12
17. Eugenin E.A., Morgello S., Klotman M.E., et al. Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. Am J Pathol 172 (2008) 1100-1111